← Back to headlines
Revolution Medicines: $40 Billion Market Cap with No Revenue Explained
Revolution Medicines holds a $40 billion market capitalization despite generating no revenue, a situation explained by its potential and pipeline in the pharmaceutical sector.
1 Jul, 20:57 — 1 Jul, 20:57
Sources
Showing 1 of 1 sources
Related Stories
Chevron Announces $7 Billion Investment to Double Oil Production in Venezuela
15m ago
Global stocks fall as US-Iran tensions spike oil and bond yields
28m ago
Apple Names John Ternus as New CEO Following Tim Cook’s Departure
34m ago
Ryanair Cuts Winter Flights and Warns of Fare Hikes Amid Soaring Fuel Costs
45m ago